4.30
0.20 (4.88%)
| Penutupan Terdahulu | 4.10 |
| Buka | 4.79 |
| Jumlah Dagangan | 4,703,334 |
| Purata Dagangan (3B) | 737,749 |
| Modal Pasaran | 154,149,424 |
| Harga / Buku (P/B) | 0.670 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 7 Nov 2024 |
| EPS Cair (TTM) | -2.08 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 3.25% |
| Nisbah Semasa (MRQ) | 17.64 |
| Aliran Tunai Operasi (OCF TTM) | -54.89 M |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Drug Manufacturers - Specialty & Generic (US) | Menurun | Bercampur |
| Drug Manufacturers - Specialty & Generic (Global) | Menurun | Bercampur | |
| Stok | BioAge Labs, Inc. | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 3.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 1.50 |
|
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. Its Products are Azelaprag (BGE-105), an apelin receptor APJ agonist that increases weight loss and improves body composition combined with incretin drugs. and BGE-100 is targeting metabolic diseases and neuroinflammation. |
|
| Sektor | Healthcare |
| Industri | Drug Manufacturers - Specialty & Generic |
| % Dimiliki oleh Orang Dalam | 3.62% |
| % Dimiliki oleh Institusi | 70.68% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Sofinnova Investments, Inc. | 30 Sep 2024 | 2,304,901 |
| Redpoint Management, Llc | 30 Sep 2024 | 383,255 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 40.00 (Morgan Stanley, 830.23%) | Beli |
| Median | 7.00 (62.79%) | |
| Rendah | 7.00 (Citigroup, 62.79%) | Pegang |
| 7.00 (Jefferies, 62.79%) | Pegang | |
| Purata | 18.00 (318.61%) | |
| Jumlah | 1 Beli, 2 Pegang | |
| Harga Purata @ Panggilan | 11.71 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Citigroup | 09 Dec 2024 | 7.00 (62.79%) | Pegang | 4.65 |
| 21 Oct 2024 | 45.00 (946.51%) | Beli | 25.83 | |
| Jefferies | 09 Dec 2024 | 7.00 (62.79%) | Pegang | 4.65 |
| 21 Oct 2024 | 42.00 (876.74%) | Beli | 25.83 | |
| Morgan Stanley | 21 Oct 2024 | 40.00 (830.23%) | Beli | 25.83 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |